| Methods |
RCT n=23 |
| Participants |
CAF |
| Interventions |
Indoramine 20 mg 6 wks vs. Placebo
n = 23 |
| Outcomes |
healing, headache |
| Notes |
14 wks f/u
AS,AC ok, B, SS no
9 drop out, 7 from Ind.
nasal congestion, dry mouth |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Random sequence generation (selection bias) |
Low risk |
ROK |
| Allocation concealment (selection bias) |
Unclear risk |
D ‐ Not used |
| Blinding (performance bias and detection bias)
All outcomes |
Unclear risk |
not stated |
| Selective reporting (reporting bias) |
Low risk |
appropriate outcomes/side effects reported |
| Other bias |
High risk |
9 drop outs |
| Duration of Follow‐up 6 months or more |
High risk |
14 weeks |
